| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Heron Therapeutics, Inc. /de/ (HRTX) has 11 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. HRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 30.05M | $28.17M | - | |
| CEO | 662.1K | $620.7K | - | |
| CFO | 215.9K | $202.4K | - | |
| COO | 188.3K | $176.6K | - | |
| Dir | 123.7K | $116.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Morgan Adam | Director | Buy | 1,766,546 | $1.50 | $2,649,819.00 | +25.3% | -16.7% | - | |
| Aug 8, 2025 | Rubric Capital Management LP | 10% Owner | Buy | 2,387,225 | $1.50 | $3,580,837.50 | +8.9% | -16.7% | - | |
| Nov 17, 2023 | Forbes William P49 | EVP, Chief Development Officer | Buy | 25,000 | $1.09 | $27,250.00 | +46.3% | +164.2% | +9.2% | |
| Nov 16, 2023 | Forbes William P49 | EVP, Chief Development Officer | Buy | 50,000 | $0.94 | $46,995.00 | +1,250% | +196.7% | +29.8% | |
| Nov 16, 2023 | Collard Craig A | Chief Executive Officer | Buy | 150,000 | $0.92 | $137,970.00 | +411.0% | +196.7% | +29.8% | |
| Nov 16, 2023 | Duarte Ira | EVP, Chief Financial Officer | Buy | 85,000 | $0.89 | $75,599.00 | New | +196.7% | +29.8% | |
| Jul 21, 2023 | Morgan Adam | Director | Buy | 2,486,744 | $1.37 | $3,406,839.28 | +55.3% | -53.8% | +135.5% | |
| May 3, 2022 | Manhard Kimberly80 | EVP, Drug Development | Sell | 1,504 | $4.76 | $7,153.63 | -12.2% | -42.3% | -50.9% | |
| Dec 21, 2021 | Christian Waage75 | Director | Sell | 300 | $9.73 | $2,920.35 | -8.6% | -47.0% | -72.2% | |
| Dec 21, 2021 | Johnson Craig A79 | Director | Sell | 250 | $9.73 | $2,431.93 | -8.1% | -47.0% | -72.2% |